NVS - MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer | Benzinga
MorphoSys AG (NASDAQ:MOR) shares are trading higher Monday following a report suggesting Novartis AG (NYSE:NVS) is in talks to acquire the company.
The Details:
According to a Reuters report, Novartis is in advanced talks to acquire MorphoSys and appears to be beating out Incyte Corporation (NASDAQ:INCY) which has also made an offer to acquire MorphoSys. The source did not specify the financial ...